The purpose of this study is to determine if zigakibart is safe and effective for long-term use in patients with immunoglobulin A nephropathy (IgAN). This is a…

Kidney DiseasesKidney Diseases, ChronicUrological Diseases+5 more

~Estimated

~$10 – $8,750

Novartis PharmaceuticalsNCT06858319

The Rutgers University Study of the Genetics of Kidney Disease

The goal of this observational study is to learn more about how genes impact the risk of kidney disease. Anyone 18 or older living in the US is eligible, and a…

Kidney DiseaseKidney Disease, ChronicKidney Disease, End-Stage+3 more

~Estimated

~$10 – $750

Rutgers, The State University of New JerseyNCT07217535